Skip to main content Accessibility help
×
Hostname: page-component-8448b6f56d-42gr6 Total loading time: 0 Render date: 2024-04-24T16:22:13.625Z Has data issue: false hasContentIssue false

Preface

Published online by Cambridge University Press:  06 October 2020

Stephen D. Silberstein
Affiliation:
Thomas Jefferson University, Philadelphia
Michael J. Marmura
Affiliation:
Thomas Jefferson University, Philadelphia
Hsiangkuo Yuan
Affiliation:
Thomas Jefferson University, Philadelphia
Stephen M. Stahl
Affiliation:
University of California, San Diego
Get access

Summary

The past few years have been extremely exciting for both neuroscientists and clinicians. We are unlocking the mysteries of the human mind and applying these discoveries to create better treatment for those affected with neurological disorders, leading to more effective therapies. A new patient-centered medicine approach will hopefully lead to fewer side effects and increased efficacy.

This edition of Essential Neuropharmacology focuses on pharmacological treatment; however, substantial improvements in surgical and medical device treatments for neurological disorders have occurred. These include surgical treatments for epilepsy, deep brain stimulation, transcranial magnetic stimulation, vagal nerve stimulation, and occipital and other nerve stimulators for pain. Due to improvements in safety and proven efficacy, some of these procedures may now be considered earlier, rather than as a last resort.

Given the expanding role of neurologists, we also decided to widen the focus of the textbook to include areas such as sleep and neuro-oncology. The practice of sleep medicine has expanded and chemotherapy has been established as effective when combined with other treatments for the treatment of some brain cancers, such as glioblastoma and CNS lymphoma, and neurologists increasingly are working with neurosurgeons and radiation oncologists to manage these challenging disorders.

Like most neurologists, we became interested in neurology due to our fascination with the nervous system and by the fact that there is so much more to learn. The scope of neurological practice continues to expand, with increasing degrees of specialization. Although we practice based on available evidence, often we must revert to trial and error for our difficult cases. Keeping track of the newest medications and developments in our expanding field is a challenge. We have all had the experience of running into a complicated patient, and we know how important it is to discuss the case with an expert. We hope that this text will help those who don't have immediate access to such expertise and will lead to better care for patients with neurological disorders.

Type
Chapter
Information
Essential Neuropharmacology
The Prescriber's Guide
, pp. xv
Publisher: Cambridge University Press
Print publication year: 2015

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Preface
  • Stephen D. Silberstein, Thomas Jefferson University, Philadelphia, Michael J. Marmura, Thomas Jefferson University, Philadelphia, Hsiangkuo Yuan, Thomas Jefferson University, Philadelphia
  • Edited in consultation with Stephen M. Stahl, University of California, San Diego
  • Book: Essential Neuropharmacology
  • Online publication: 06 October 2020
  • Chapter DOI: https://doi.org/10.1017/9781316161753.001
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Preface
  • Stephen D. Silberstein, Thomas Jefferson University, Philadelphia, Michael J. Marmura, Thomas Jefferson University, Philadelphia, Hsiangkuo Yuan, Thomas Jefferson University, Philadelphia
  • Edited in consultation with Stephen M. Stahl, University of California, San Diego
  • Book: Essential Neuropharmacology
  • Online publication: 06 October 2020
  • Chapter DOI: https://doi.org/10.1017/9781316161753.001
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Preface
  • Stephen D. Silberstein, Thomas Jefferson University, Philadelphia, Michael J. Marmura, Thomas Jefferson University, Philadelphia, Hsiangkuo Yuan, Thomas Jefferson University, Philadelphia
  • Edited in consultation with Stephen M. Stahl, University of California, San Diego
  • Book: Essential Neuropharmacology
  • Online publication: 06 October 2020
  • Chapter DOI: https://doi.org/10.1017/9781316161753.001
Available formats
×